Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Boston Scientific Corporation BSX-PA NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
76/100
5/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Metric TTM (2025-03 – 2025-12)
Revenue $20.08B
Gross Profit $14.11B
Gross Margin 70.3%
Operating Income $4B
Net Income $2.89B
Net Margin 14.4%
EPS (Diluted) $1.93

People Also View

C-PK
C-PK
Citigroup Inc.
$24.99
-0.04%
 APTV-PA
APTV-PA
Aptiv PLC
$108.66
+0.15%
 BDXB
BDXB
Becton, Dickinson and Company
$48.16
+1.39%
 CFG-PE
CFG-PE
Citizens Financial Group, Inc.
$19.03
+0.32%
 DLR-PL
DLR-PL
Digital Realty Trust, Inc.
$19.87
+0.65%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message